Delivery Order SPE2DB20D3103-SPE2DB26FL4H7
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Fulvestrant 250 mg/5 mL syringes (5 mL quantity) with a contract ceiling value of $1,224.00. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and was awarded competitively without set-aside restrictions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,530.00 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Fulvestrant 250 mg/5 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order fulfillment under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fulvestrant 250 mg/5 mL syringes with a ceiling value of $1,145.70. This non-set-aside, competitively awarded delivery order features firm fixed pricing and is scheduled for completion by August 8, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fulvestrant 250 mg/5 ml syringes, a specialty medication, under a delivery order valued at $1,231.10. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,145.70, is for the supply of 4567954913 FULVESTRANT 250 MG/5 ML SYRING 5ML, a pharmaceutical product, with a period of performance through April 18, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,097.53 firm-fixed price delivery order is for the supply of 4566293391 FULVESTRANT 250 MG/5 ML SYRING 5ML, a specialty pharmaceutical product, with an ultimate completion date of November 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,060.00 firm-fixed-price contract is for the supply of 4567008677 - Fulvestrant 250 mg/5 ml syringes. The contract has a completion date of January 23, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,925.78 firm-fixed-price delivery order is for the supply of 4567007117 - FULVESTRANT 250 MG/5 ML SYRING 5ML, a specialty pharmaceutical product. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $4,787.50 to AmerisourceBergen Drug Corp for the supply of Fulphila 6 mg/0.6 mL syringes on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The product will be delivered to the...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 22, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply FULPHILA 6 mg/0.6 mL syringes with a contract value of $10,523.70. The delivery order is structured as a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. Performance of this delivery order will be completed by July 23, 2025, at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4H7Delivery Order
The Defense Logistics Agency awarded a $1,020.00 delivery order to AmerisourceBergen Drug Corp for Fulvestrant 250 mg/5 mL syringes on October 29, 2025, with completion targeted for October 30, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a single transaction under a competitive procurement process for pharmaceutical supply. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling flexible delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract supports federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a critical vendor within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/29/25 |